octagam 50 mg/ml oldatos infúzió
octapharma (ip) sprl - immunglobulin (humán) -
gamunex 100 mg/ml oldatos infúzió
grifols deutschland gmbh - immunglobulin (humán) -
octagam 100 mg/ml oldatos infúzió
octapharma (ip) sprl - immunglobulin (humán) -
valsol 40 mg filmtabletta
laboratorios liconsa sa - a valzartán -
eptifibatide mylan 0,75 mg/ml oldatos infúzió
mylan s.a.s. - eptifibatidet -
eptifibatide mylan 2 mg/ml oldatos injekció
mylan s.a.s. - eptifibatidet -
humaglobin liquid 50 g/l oldatos infúzió
human bioplazma kft. - immunglobulin (humán) -
iqymune 100 mg/ml oldatos infúzió
lfb - humán normál immunglobulin -
panzyga 100 mg/ml oldatos infúzió
octapharma (ip) sprl - a humán normál immunglobulin az intravénás beadásra. -
clopidogrel acino
acino ag - clopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitrombotikus szerek - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.